Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
IM Cannabis Corp ( (IMCC) ) has shared an announcement.
IM Cannabis Corp. has received a notification from Nasdaq that it is not in compliance with the exchange’s minimum bid price requirement of $1.00 per share, triggering a 180-day grace period to regain compliance. The company’s shares will continue trading on the Nasdaq Capital Market under the symbol IMCC during this period, with the possibility of a second 180-day extension if it meets other listing standards.
IM Cannabis has until October 6, 2026, to lift its closing bid price to at least $1.00 for ten consecutive business days or risk potential delisting from Nasdaq. Management has stated that maintaining the Nasdaq listing is a priority and that it will monitor the share price and consider available options to cure the deficiency, a development that may influence investor confidence and the company’s access to capital markets.
The notice does not immediately affect the company’s operations in Israel and Germany, where it continues to import, distribute, and retail medical cannabis to patients and pharmacies. However, the listing uncertainty highlights ongoing market pressures facing smaller international cannabis operators and could impact perceptions of IM Cannabis’s financial stability if compliance is not restored within the allowed timeframe.
The most recent analyst rating on (IMCC) stock is a Hold with a $0.30 price target. To see the full list of analyst forecasts on IM Cannabis Corp stock, see the IMCC Stock Forecast page.
Spark’s Take on IMCC Stock
According to Spark, TipRanks’ AI Analyst, IMCC is a Underperform.
The score is held down primarily by stressed fundamentals (negative equity and ongoing losses) despite improved 2025 cash flow, and by very bearish technical signals with the stock trading far below key moving averages. Valuation provides limited support because the company is currently loss-making and no dividend yield is available.
To see Spark’s full report on IMCC stock, click here.
More about IM Cannabis Corp
IM Cannabis Corp. is an international medical cannabis company operating in Israel and Germany, focused on building and scaling innovative businesses and technologies across global markets. Through subsidiaries, it imports and distributes medical cannabis, runs retail pharmacies and online platforms in Israel, and supplies pharmacies serving medical patients in Germany via Adjupharm GmbH.
The company leverages proprietary patient data and insights to support its medical cannabis platform and ensure quality control throughout the value chain. It is also evaluating opportunities to expand into additional technology-driven sectors beyond its current cannabis operations, aiming to grow its presence and capabilities in regulated healthcare-related markets.
Average Trading Volume: 277,029
Technical Sentiment Signal: Sell
Current Market Cap: $2.21M
For detailed information about IMCC stock, go to TipRanks’ Stock Analysis page.